chr1-11846856-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_006172.4(NPPA):c.450+257G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.136 in 151,000 control chromosomes in the GnomAD database, including 2,137 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.14 ( 2137 hom., cov: 28)
Consequence
NPPA
NM_006172.4 intron
NM_006172.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.31
Genes affected
NPPA (HGNC:7939): (natriuretic peptide A) The protein encoded by this gene belongs to the natriuretic peptide family. Natriuretic peptides are implicated in the control of extracellular fluid volume and electrolyte homeostasis. This protein is synthesized as a large precursor (containing a signal peptide), which is processed to release a peptide from the N-terminus with similarity to vasoactive peptide, cardiodilatin, and another peptide from the C-terminus with natriuretic-diuretic activity. Mutations in this gene have been associated with atrial fibrillation familial type 6. This gene is located adjacent to another member of the natriuretic family of peptides on chromosome 1. [provided by RefSeq, Oct 2015]
CLCN6 (HGNC:2024): (chloride voltage-gated channel 6) This gene encodes a member of the voltage-dependent chloride channel protein family. Members of this family can function as either chloride channels or antiporters. This protein is primarily localized to late endosomes and functions as a chloride/proton antiporter. Alternate splicing results in both coding and non-coding variants. Additional alternately spliced variants have been described but their full-length structure is unknown. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.07).
BP6
Variant 1-11846856-C-G is Benign according to our data. Variant chr1-11846856-C-G is described in ClinVar as [Benign]. Clinvar id is 1182455.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.285 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPPA | ENST00000376480.7 | c.450+257G>C | intron_variant | Intron 2 of 2 | 1 | NM_006172.4 | ENSP00000365663.3 | |||
CLCN6 | ENST00000446542.5 | n.782-578C>G | intron_variant | Intron 3 of 3 | 1 | |||||
NPPA | ENST00000376476.1 | c.300+257G>C | intron_variant | Intron 2 of 2 | 3 | ENSP00000365659.1 | ||||
CLCN6 | ENST00000400892.3 | n.*1962-721C>G | intron_variant | Intron 26 of 26 | 3 | ENSP00000496938.1 |
Frequencies
GnomAD3 genomes AF: 0.136 AC: 20471AN: 150884Hom.: 2136 Cov.: 28 show subpopulations
GnomAD3 genomes
AF:
AC:
20471
AN:
150884
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.136 AC: 20486AN: 151000Hom.: 2137 Cov.: 28 AF XY: 0.133 AC XY: 9795AN XY: 73786 show subpopulations
GnomAD4 genome
AF:
AC:
20486
AN:
151000
Hom.:
Cov.:
28
AF XY:
AC XY:
9795
AN XY:
73786
Gnomad4 AFR
AF:
AC:
0.289403
AN:
0.289403
Gnomad4 AMR
AF:
AC:
0.088185
AN:
0.088185
Gnomad4 ASJ
AF:
AC:
0.0514451
AN:
0.0514451
Gnomad4 EAS
AF:
AC:
0.00660451
AN:
0.00660451
Gnomad4 SAS
AF:
AC:
0.0942059
AN:
0.0942059
Gnomad4 FIN
AF:
AC:
0.0382917
AN:
0.0382917
Gnomad4 NFE
AF:
AC:
0.0861983
AN:
0.0861983
Gnomad4 OTH
AF:
AC:
0.134762
AN:
0.134762
Heterozygous variant carriers
0
751
1503
2254
3006
3757
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
201
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Sep 04, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at